Fundraising Fox
Eigen Therapeutics
Redwood City, US · 3 known investors
Find your way into Eigen Therapeutics
Sign up to see every warm intro you have to Eigen Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eigen Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
Investors · 3
__Twitter.png)
Frequently asked questions
- What does Eigen Therapeutics do?
- Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
- Who are Eigen Therapeutics's investors?
- Eigen Therapeutics's investors include Gaingels, SBXi, ZAKA VC.
- Where is Eigen Therapeutics headquartered?
- Eigen Therapeutics is headquartered in Redwood City, US.